News

Published on 20 Nov 2024 on Zacks · via Yahoo Finance

ZBH Stock Gains From Receiving CE Mark for Persona Revision Knee System


Article preview image

Zimmer Biomet gets CE Mark Certification for Persona Revision Knee System, followed by the...

NYSE.RMD price evolution
NYSE.ZBH price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
ZBH Stock Gains From FDA Nod for Oxford Cementless Partial Knee

Zimmer Biomet receives FDA nod for the Oxford Cementless Partial Knee. It is a PMA Supplement...

Zacks · via Yahoo Finance 26 Nov 2024

Zacks.com featured highlights include InterDigital, Greenbrier, Leidos, ResMed...

(GBX Quick QuoteGBX - Free Report) , Leidos Holdings Inc. (LDOS Quick QuoteLDOS - Free Report) ,...

Zacks 26 Nov 2024

GMED Stock Might Rise From the Commercial Launch of Its ExcelsiusHub

Some other top-ranked stocks in the broader medical space are Haemonetics HAE, Penumbra PEN, and...

Zacks · via Yahoo Finance 25 Nov 2024

This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar

ResMed was upgraded to the Zacks Rank #1 list on November 14, 2024. The Zacks Rank is a unique...

Zacks · via Yahoo Finance 21 Nov 2024

HSIC Stock Likely to Gain From Its Latest Acquisition of Acentus

Henry Schein, Inc. HSIC recently entered into an agreement to acquire Acentus, a national medical...

Zacks · via Yahoo Finance 21 Nov 2024

ZBH Stock Gains From Receiving CE Mark for Persona Revision Knee System

Zimmer Biomet gets CE Mark Certification for Persona Revision Knee System, followed by the...

Zacks · via Yahoo Finance 20 Nov 2024

Merit Medical Stock Gains 37.9% Year to Date: What's Behind the Rally?

Price Merit Medical Systems, Inc. price | Merit Medical Systems, Inc. Quote Key Picks Some other...

Zacks · via Yahoo Finance 20 Nov 2024

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

On Your Watchlist Different than value or momentum investors, growth-oriented investors are...

Zacks · via Yahoo Finance 20 Nov 2024

ResMed's (NYSE:RMD) earnings growth rate lags the 11% CAGR delivered to...

If you buy and hold a stock for many years, you'd hope to be making a profit. Better yet, you'd l...

Simply Wall St. · via Yahoo Finance 18 Nov 2024

Here's Why You Should Add RMD Stock to Your Portfolio Now

ResMed Inc.’s RMD growth in the first quarter of fiscal 2025 can be attributed to the robust...

Zacks · via Yahoo Finance 15 Nov 2024